NCT04704934 2026-01-12Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)Daiichi SankyoPhase 3 Active not recruiting490 enrolled
NCT01616303 2020-09-14A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian CancerQuest PharmaTech Inc.Phase 2 Completed97 enrolled
NCT02077881 2020-05-28Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic CancerLumos PharmaPhase 1/2 Completed157 enrolled
NCT01310244 2020-01-06MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLCAcrotech Biopharma Inc.Phase 1/2 Completed23 enrolled
NCT01253525 2014-06-18Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric AdenocarcinomasEli Lilly and CompanyPhase 1 Completed6 enrolled 18 charts
NCT00600821 2013-11-08A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.PfizerPhase 2 Completed118 enrolled 12 charts